20-46035854-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_020708.5(SLC12A5):​c.357G>T​(p.Arg119Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0705 in 1,614,046 control chromosomes in the GnomAD database, including 4,329 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. R119R) has been classified as Benign.

Frequency

Genomes: 𝑓 0.067 ( 355 hom., cov: 32)
Exomes 𝑓: 0.071 ( 3974 hom. )

Consequence

SLC12A5
NM_020708.5 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.84

Publications

5 publications found
Variant links:
Genes affected
SLC12A5 (HGNC:13818): (solute carrier family 12 member 5) K-Cl cotransporters are proteins that lower intracellular chloride concentrations below the electrochemical equilibrium potential. The protein encoded by this gene is an integral membrane K-Cl cotransporter that can function in either a net efflux or influx pathway, depending on the chemical concentration gradients of potassium and chloride. The encoded protein can act as a homomultimer, or as a heteromultimer with other K-Cl cotransporters, to maintain chloride homeostasis in neurons. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Sep 2008]
SLC12A5 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 34
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), Illumina
  • epilepsy of infancy with migrating focal seizures
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, idiopathic generalized, susceptibility to, 14
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, PanelApp Australia, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020708.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 20-46035854-G-T is Benign according to our data. Variant chr20-46035854-G-T is described in ClinVar as Benign. ClinVar VariationId is 1166970.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.84 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0752 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020708.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC12A5
NM_020708.5
MANE Select
c.357G>Tp.Arg119Arg
synonymous
Exon 4 of 26NP_065759.1Q9H2X9-2
SLC12A5
NM_001134771.2
c.426G>Tp.Arg142Arg
synonymous
Exon 4 of 26NP_001128243.1Q9H2X9-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC12A5
ENST00000243964.7
TSL:1 MANE Select
c.357G>Tp.Arg119Arg
synonymous
Exon 4 of 26ENSP00000243964.4Q9H2X9-2
SLC12A5
ENST00000616202.4
TSL:1
c.357G>Tp.Arg119Arg
synonymous
Exon 4 of 7ENSP00000478369.1M4PM71
SLC12A5
ENST00000626937.2
TSL:1
c.357G>Tp.Arg119Arg
synonymous
Exon 4 of 7ENSP00000485953.1M4PNC0

Frequencies

GnomAD3 genomes
AF:
0.0667
AC:
10154
AN:
152178
Hom.:
355
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0599
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.0758
Gnomad ASJ
AF:
0.106
Gnomad EAS
AF:
0.000576
Gnomad SAS
AF:
0.0191
Gnomad FIN
AF:
0.0504
Gnomad MID
AF:
0.185
Gnomad NFE
AF:
0.0769
Gnomad OTH
AF:
0.101
GnomAD2 exomes
AF:
0.0597
AC:
14989
AN:
251202
AF XY:
0.0595
show subpopulations
Gnomad AFR exome
AF:
0.0606
Gnomad AMR exome
AF:
0.0512
Gnomad ASJ exome
AF:
0.0993
Gnomad EAS exome
AF:
0.000217
Gnomad FIN exome
AF:
0.0464
Gnomad NFE exome
AF:
0.0786
Gnomad OTH exome
AF:
0.0916
GnomAD4 exome
AF:
0.0709
AC:
103594
AN:
1461750
Hom.:
3974
Cov.:
33
AF XY:
0.0698
AC XY:
50758
AN XY:
727182
show subpopulations
African (AFR)
AF:
0.0612
AC:
2048
AN:
33480
American (AMR)
AF:
0.0524
AC:
2345
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
2632
AN:
26120
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39700
South Asian (SAS)
AF:
0.0249
AC:
2151
AN:
86254
European-Finnish (FIN)
AF:
0.0517
AC:
2762
AN:
53400
Middle Eastern (MID)
AF:
0.123
AC:
712
AN:
5766
European-Non Finnish (NFE)
AF:
0.0775
AC:
86150
AN:
1111936
Other (OTH)
AF:
0.0793
AC:
4786
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
5672
11344
17016
22688
28360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3120
6240
9360
12480
15600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0667
AC:
10163
AN:
152296
Hom.:
355
Cov.:
32
AF XY:
0.0637
AC XY:
4741
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0600
AC:
2494
AN:
41548
American (AMR)
AF:
0.0757
AC:
1159
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.106
AC:
368
AN:
3470
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5192
South Asian (SAS)
AF:
0.0191
AC:
92
AN:
4824
European-Finnish (FIN)
AF:
0.0504
AC:
535
AN:
10620
Middle Eastern (MID)
AF:
0.182
AC:
53
AN:
292
European-Non Finnish (NFE)
AF:
0.0769
AC:
5230
AN:
68018
Other (OTH)
AF:
0.0995
AC:
210
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
496
993
1489
1986
2482
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0761
Hom.:
1059
Bravo
AF:
0.0687
Asia WGS
AF:
0.0200
AC:
70
AN:
3478
EpiCase
AF:
0.0876
EpiControl
AF:
0.0888

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Developmental and epileptic encephalopathy, 34 (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
5.1
DANN
Benign
0.61
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs77659338;
hg19: chr20-44664493;
COSMIC: COSV54792563;
COSMIC: COSV54792563;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.